These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 11487306

  • 1. Essential fatty acids as possible mediators of the actions of statins.
    Das UN.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):37-40. PubMed ID: 11487306
    [Abstract] [Full Text] [Related]

  • 2. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H.
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [Abstract] [Full Text] [Related]

  • 3. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
    Farooqui AA, Ong WY, Horrocks LA, Chen P, Farooqui T.
    Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
    [Abstract] [Full Text] [Related]

  • 4. Toward a role for statins in immunomodulation.
    Mach F.
    Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
    [Abstract] [Full Text] [Related]

  • 5. Biological significance of essential fatty acids.
    Das UN.
    J Assoc Physicians India; 2006 Apr; 54():309-19. PubMed ID: 16944615
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR, Anel RL, Zeng L, Lomasney J, Sahai A, Kanwar YS.
    Arch Immunol Ther Exp (Warsz); 2003 Apr; 51(3):139-48. PubMed ID: 12894868
    [Abstract] [Full Text] [Related]

  • 7. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
    Manzoni M, Rollini M.
    Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
    [Abstract] [Full Text] [Related]

  • 8. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW, Lefer DJ.
    Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
    [Abstract] [Full Text] [Related]

  • 9. Beneficial cardiovascular pleiotropic effects of statins.
    Davignon J.
    Circulation; 2004 Jun 15; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
    [Abstract] [Full Text] [Related]

  • 10. [Arginine and statins: relationship between the nitric oxide pathway and the atherosclerosis development].
    Rasmusen C, Cynober L, Couderc R.
    Ann Biol Clin (Paris); 2005 Jun 15; 63(5):443-55. PubMed ID: 16230278
    [Abstract] [Full Text] [Related]

  • 11. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W, Köenig W.
    J Cardiovasc Risk; 2003 Jun 15; 10(3):169-79. PubMed ID: 12775949
    [Abstract] [Full Text] [Related]

  • 12. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW.
    Metabolism; 2001 Oct 15; 50(10):1234-41. PubMed ID: 11586500
    [Abstract] [Full Text] [Related]

  • 13. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM.
    Curr Opin Investig Drugs; 2002 Sep 15; 3(9):1312-7. PubMed ID: 12498006
    [Abstract] [Full Text] [Related]

  • 14. The pro- and antiangiogenic effects of statins.
    Skaletz-Rorowski A, Kureishi Y, Shiojima I, Walsh K.
    Semin Vasc Med; 2004 Nov 15; 4(4):395-400. PubMed ID: 15861320
    [Abstract] [Full Text] [Related]

  • 15. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
    Luan Z, Chase AJ, Newby AC.
    Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):769-75. PubMed ID: 12663370
    [Abstract] [Full Text] [Related]

  • 16. Potential therapeutic role of statins in neurological disorders.
    Bifulco M, Malfitano AM, Marasco G.
    Expert Rev Neurother; 2008 May 01; 8(5):827-37. PubMed ID: 18457539
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids.
    Das UN.
    Exp Biol Med (Maywood); 2002 Feb 01; 227(2):88-93. PubMed ID: 11815671
    [Abstract] [Full Text] [Related]

  • 18. Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link?
    Das UN.
    Nutrition; 2002 Feb 01; 18(2):178-88. PubMed ID: 11844650
    [Abstract] [Full Text] [Related]

  • 19. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension.
    Das UN.
    Eur J Clin Nutr; 2004 Feb 01; 58(2):195-203. PubMed ID: 14749737
    [Abstract] [Full Text] [Related]

  • 20. [Essential fatty acids in cardiovascular physiopathology].
    Vles RO.
    Ann Nutr Aliment; 1980 Feb 01; 34(2):255-63. PubMed ID: 7001987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.